Reimbursement incentives could promote antibiotic research and development—in particular, for new drugs to treat complex infections commonly found in hospitals.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: